证券记录 · 已归档季度
ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
14被追踪持有人
+2Δ持有人
37.00M持有股份
$634.64M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +16.7% ·
股份流向 -4.4% ·
净新建仓位 +14.3%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 14.87M | — | $255.03M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 5.43M | +0.9% | $93.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 5.43M | +0.9% | $93.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 3.77M | +2.8% | $64.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 3.07M | -41.8% | $52.59M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 3.07M | -41.8% | $52.59M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 2.76M | +57.9% | $47.38M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 2.55M | -29.0% | $43.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 2.10M | 0.0% | $36.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.10M | 0.0% | $36.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.16M | +3.8% | $19.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 212.33K | +91.3% | $3.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 166.69K | +1.3% | $2.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 158.43K | 新增 | $2.72M | 0.0% | New | 1 | SEC ↗ |
| 18 | Norges Bank ✦ (被动) | 119.34K | 新增 | $2.05M | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $2.72M | 0.0% |
| Norges Bank | $2.05M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 355 持有人, 211.31M 股份, $1.84B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据